Overview of the Canadian pediatric end-stage renal disease database

<p>Abstract</p> <p>Background</p> <p>Performing clinical research among pediatric end-stage renal disease patients is challenging. Barriers to successful initiation and completion of clinical research projects include small sample sizes and resultant limited statistical power and lack of longitudinal follow-up for hard clinical end-points in most single center studies.</p> <p>Description</p> <p>Existing longitudinal organ failure disease registry and administrative health datasets available within a universal access health care system can be used to study outcomes of end-stage renal disease among pediatric patients in Canada. To construct the Canadian Pediatric End-Stage Renal Disease database, registry data were linked to administrative health data through deterministic linkage techniques creating a research database which consists of socio-demographic variables, clinical variables, all-cause hospitalizations, and relevant outcomes (death and renal allograft loss) for this patient population. The research database also allows study of major cardiovascular events using previously validated administrative data definitions.</p> <p>Conclusion</p> <p>Organ failure registry linked to health administrative data can be a powerful tool to perform longitudinal studies in pediatric end-stage renal disease patients. The rich clinical and demographic information found in this database will facilitate study of important medical and non-medical risk factors for death, graft loss and cardiovascular disease among pediatric end-stage renal disease patients.</p

Implications of a 125 GeV Higgs scalar for LHC SUSY and neutralino dark matter searches

The ATLAS and CMS collaborations have reported an excess of events in the \gamma\gamma, ZZ^*\to 4\ell and WW^* search channels at an invariant mass m \simeq 125 GeV, which could be the first evidence for the long-awaited Higgs boson. We investigate the consequences of requiring m_h\simeq 125 GeV in both the mSUGRA and NUHM2 SUSY models. In mSUGRA, large values of trilinear soft breaking parameter |A_0| are required, and universal scalar m_0\agt 0.8 TeV is favored so that we expect squark and slepton masses typically in the multi-TeV range. This typically gives rise to an "effective SUSY" type of sparticle mass spectrum. In this case, we expect gluino pair production as the dominant sparticle creation reaction at LHC. For m_0< 5 TeV, the superpotential parameter \mu > 2 TeV and m_A> 0.8 TeV, greatly restricting neutralino annihilation mechanisms. These latter conclusions are softened if m_0\sim 10-20 TeV or if one proceeds to the NUHM2 model. The standard neutralino abundance tends to be far above WMAP-measured values unless the neutralino is higgsino-like. We remark upon possible non-standard (but perhaps more attractive) cosmological scenarios which can bring the predicted dark matter abundance into accord with the measured value, and discuss the implications for direct and indirect detection of neutralino cold dark matter.Comment: 24 pages including 23 .eps figures; updated version 3 contains also b-> tau+nu branching fractio

Depression after Delivery: Risk Factors, Diagnostic and Therapeutic Considerations

Postpartum mood disorders can negatively affect women, their offspring, and their families when left untreated. The identification and treatment of postpartum depression remains problematic since health care providers may often not differentiate postpartum blues from depression onset. Recent studies found potentially new risk factors, etiologies, and treatments; thus, possibly improving the untreated postpartum depression rates. This integrated review examined several postpartum psychiatric disorders, postpartum blues, generalized anxiety, obsessive compulsive disorder, post-traumatic stress disorder, and postpartum psychosis for current findings on prevalence, etiologies, risk factors, and postpartum depression treatments

Population based screening for chronic kidney disease: cost effectiveness study

Objective To determine the cost effectiveness of one-off population based screening for chronic kidney disease based on estimated glomerular filtration rate

Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease : a prospective cohort study

Background : Soluble tumor necrosis factor receptors 1 (sTNFR1) and 2 (sTNFR2) have been associated to progression of renal failure, end stage renal disease and mortality in early stages of chronic kidney disease (CKD), mostly in the context of diabetic nephropathy. The predictive value of these markers in advanced stages of CKD irrespective of the specific causes of kidney disease has not yet been defined. In this study, the relationship between sTNFR1 and sTNFR2 and the risk for adverse cardiovascular events (CVE) and all-cause mortality was investigated in a population with CKD stage 4-5, not yet on dialysis, to minimize the confounding by renal function. Patients and methods : In 131 patients, CKD stage 4-5, sTNFR1, sTNFR2 were analysed for their association to a composite endpoint of all-cause mortality or first non-fatal CVE by univariate and multivariate Cox proportional hazards models. In the multivariate models, age, gender, CRP, eGFR and significant comorbidities were included as covariates. Results : During a median follow-up of 33 months, 40 events (30.5%) occurred of which 29 deaths (22.1%) and 11 (8.4%) first non-fatal CVE. In univariate analysis, the hazard ratios (HR) of sTNFR1 and sTNFR2 for negative outcome were 1.49 (95% confidence interval (CI): 1.28-1.75) and 1.13 (95% CI: 1.06-1.20) respectively. After adjustment for clinical covariables (age, CRP, diabetes and a history of cardiovascular disease) both sTNFRs remained independently associated to outcomes (HR: sTNFR1: 1.51, 95% CI: 1.30-1.77; sTNFR2: 1.13, 95% CI: 1.06-1.20). A subanalysis of the non-diabetic patients in the study population confirmed these findings, especially for sTNFR1. Conclusion : sTNFR1 and sTNFR2 are independently associated to all-cause mortality or an increased risk for cardiovascular events in advanced CKD irrespective of the cause of kidney disease

Physics at the LHC: a short overview

The CERN Large Hadron Collider (LHC) started operation a few months ago. The machine will deliver proton-proton and nucleus-nucleus collisions at energies as high as sqrt(s)=14 TeV and luminosities up to L~10^{34} cm^{-2}s^{-1}, never reached before. The main open scientific questions that the seven LHC experiments -- ATLAS, CMS, ALICE, LHCb, TOTEM, LHCf and MOEDAL -- aim to solve in the coming years are succinctly reviewed.Comment: 9 pages, 16 plots. Invited review talk Hot-Quarks 2010, La Londe-Les-Maures, July 2010. J. Phys. Conf. Ser. 270, 012001 (2011). Minor typos correcte

Over-expression of the Arabidopsis AtMYB41 gene alters cell expansion and leaf surface permeability

The Arabidopsis AtMYB41 gene encodes an R2R3-MYB transcription factor whose expression is not detectable under normal growth conditions in any organ or at any developmental stage analysed. It is expressed at high levels in response to drought, ABA and salt treatments, suggesting a possible role in stress responses. Transgenic lines over-expressing this transcription factor showed a pleiotropic phenotype similar to that exhibited by some mutants that affect cuticle biosynthesis. This includes a dwarf appearance, dependent on smaller cells with abnormal morphology, enhanced sensitivity to desiccation, and enhanced permeability of leaf surfaces, suggesting discontinuity in the cuticle. The expression of genes involved in lipid metabolism and transport, in cell-wall modifications and cell expansion, genes coding for membrane-associated proteins and genes specifically involved in cuticle metabolism was differentially modulated between wild-type and transgenic plants, suggesting a direct or indirect role of AtMYB41 in the regulation of their transcription. Taken together, our results suggest that AtMYB41 is part of a complex network of transcription factors controlling cell expansion and cuticle deposition in response to abiotic stress